About

Rootline exists to support clear, evidence-aware understanding of the differences between iboga and ibogaine, including cultural context, research, regulation, and risk. The aim is not to direct anyone toward treatment or use, but to make it easier to identify the questions worth taking to qualified professionals.

Information is organized so that readers can distinguish broad context from practical considerations, and established findings from preliminary or incomplete evidence. The main guide to iboga and ibogaine provides an entry point, while the resource’s scope of information and guidance explains the boundaries of what Rootline does and does not provide.

Rootline uses published literature, public registries, official materials, and primary sources where possible. The approach follows the basic logic of the U.S. National Library of Medicine: sources should be identifiable, context should be preserved, and uncertainty should not be hidden behind a confident tone.

When an important question has no settled answer, that limitation belongs in the explanation. This is especially important for health-adjacent topics, where a summary can be useful without becoming a substitute for clinical or legal judgment.

Rootline is intended for readers who want orientation without pressure: people comparing terms, preparing better questions, or trying to understand the difference between a claim and the evidence behind it. For examples of the kinds of practical questions readers encounter, the discussion of regional treatment context in Arizona can help show why local details should never be assumed to apply everywhere.

Personal accounts can offer perspective but cannot establish safety or effectiveness. A first-person trip account is best read as one person’s experience, not as a general recommendation or a clinical conclusion.

Cost, access, and stated services can also vary widely. Readers weighing descriptions of retreat costs and arrangements should keep commercial information separate from evidence, screening, and individualized professional advice.

For health-related questions, Rootline points readers toward reliable source types and clear language about limits. The FDA’s overview of drug development and approval illustrates why early study, availability, and established clinical use are not interchangeable categories.